Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7135 | 1325 | 44.6 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AURORA A | Author keyword | 141 | 63% | 11% | 141 |
2 | AURORA KINASES | Author keyword | 86 | 77% | 4% | 59 |
3 | AURORA KINASE | Author keyword | 83 | 56% | 8% | 102 |
4 | AZD1152 | Author keyword | 62 | 92% | 2% | 24 |
5 | AURORA KINASE INHIBITOR | Author keyword | 53 | 79% | 3% | 34 |
6 | MLN8237 | Author keyword | 52 | 87% | 2% | 26 |
7 | AURKA | Author keyword | 48 | 73% | 3% | 37 |
8 | AURORA B | Author keyword | 46 | 45% | 6% | 78 |
9 | AURORA A KINASE | Author keyword | 40 | 69% | 3% | 34 |
10 | AURORA KINASE INHIBITORS | Author keyword | 40 | 77% | 2% | 27 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AURORA A | 141 | 63% | 11% | 141 | Search AURORA+A | Search AURORA+A |
2 | AURORA KINASES | 86 | 77% | 4% | 59 | Search AURORA+KINASES | Search AURORA+KINASES |
3 | AURORA KINASE | 83 | 56% | 8% | 102 | Search AURORA+KINASE | Search AURORA+KINASE |
4 | AZD1152 | 62 | 92% | 2% | 24 | Search AZD1152 | Search AZD1152 |
5 | AURORA KINASE INHIBITOR | 53 | 79% | 3% | 34 | Search AURORA+KINASE+INHIBITOR | Search AURORA+KINASE+INHIBITOR |
6 | MLN8237 | 52 | 87% | 2% | 26 | Search MLN8237 | Search MLN8237 |
7 | AURKA | 48 | 73% | 3% | 37 | Search AURKA | Search AURKA |
8 | AURORA B | 46 | 45% | 6% | 78 | Search AURORA+B | Search AURORA+B |
9 | AURORA A KINASE | 40 | 69% | 3% | 34 | Search AURORA+A+KINASE | Search AURORA+A+KINASE |
10 | AURORA KINASE INHIBITORS | 40 | 77% | 2% | 27 | Search AURORA+KINASE+INHIBITORS | Search AURORA+KINASE+INHIBITORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | A KINASE | 190 | 65% | 14% | 182 |
2 | B KINASE | 180 | 69% | 12% | 153 |
3 | DROSOPHILA AURORA | 94 | 94% | 2% | 33 |
4 | CHROMOSOMAL PASSENGER PROTEIN | 70 | 82% | 3% | 41 |
5 | CENTROSOME AMPLIFICATION | 53 | 31% | 11% | 145 |
6 | VX 680 | 50 | 75% | 3% | 36 |
7 | AURORA IP11 RELATED PROTEIN KINASE | 49 | 94% | 1% | 17 |
8 | AZD1152 | 49 | 94% | 1% | 17 |
9 | PHE31ILE POLYMORPHISM | 48 | 100% | 1% | 17 |
10 | BIPOLAR MITOTIC SPINDLE | 44 | 88% | 2% | 21 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The aurora kinases in cell cycle and leukemia | 2015 | 8 | 143 | 66% |
Aurora kinase inhibitors: Progress towards the clinic | 2012 | 59 | 74 | 91% |
Aurora A kinase (AURKA) in normal and pathological cell division | 2013 | 42 | 236 | 60% |
Aurora-A - A guardian of poles | 2005 | 406 | 96 | 71% |
Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics? | 2010 | 110 | 66 | 74% |
Update on aurora kinase targeted therapeutics in oncology | 2011 | 45 | 70 | 96% |
Roles of aurora kinases in mitosis and tumorigenesis | 2007 | 238 | 108 | 74% |
Shared and separate functions of polo-like kinases and aurora kinases in cancer | 2010 | 223 | 219 | 32% |
Discovery and Development of Aurora Kinase Inhibitors as Anticancer Agents | 2009 | 104 | 127 | 69% |
Chromosomal passengers: conducting cell division | 2007 | 483 | 157 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP CYCLE CELLULAIRE | 9 | 50% | 1.0% | 13 |
2 | REGULATORY RADIOBIOL | 8 | 50% | 0.8% | 11 |
3 | MOL PATHOBIOCHEM | 4 | 25% | 1.0% | 13 |
4 | YORKSHIRE CANC CANC STUDIES | 3 | 60% | 0.2% | 3 |
5 | WELLCOME CELL BIOL | 2 | 36% | 0.4% | 5 |
6 | DEV SIGNAL TRANSDUCT GRP | 2 | 67% | 0.2% | 2 |
7 | PATHOL EXPT MED CLIN | 2 | 50% | 0.2% | 3 |
8 | SINO US JOINT MED SCI | 2 | 22% | 0.5% | 7 |
9 | SUN YAT SEN HEMATOL | 1 | 38% | 0.2% | 3 |
10 | CNRSUPR 41 | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000141215 | KINETOCHORE//SPINDLE ASSEMBLY CHECKPOINT//MAD2 |
2 | 0.0000130240 | POLO LIKE KINASE 1//POLO BOX DOMAIN//PLK1 |
3 | 0.0000114538 | EG5//KINESIN SPINDLE PROTEIN//KINESIN 5 |
4 | 0.0000090707 | CYTOKINESIS//CLEAVAGE FURROW//CENTRALSPINDLIN |
5 | 0.0000082562 | REVERSINE//MITOTIC CATASTROPHE//WP 631 |
6 | 0.0000081291 | NIMA//NEK6//NEK2 |
7 | 0.0000075814 | COFFIN LOWRY SYNDROME//RSK2//SL0101 |
8 | 0.0000065547 | CENTROSOME//CENTRIOLE//CENTRIN |
9 | 0.0000061417 | SURVIVIN//YM155//SURVIVIN EXPRESSION |
10 | 0.0000049300 | FBXW7//FBW7//HCDC4 |